TY - JOUR
T1 - Assessing the rate, natural history, and treatment trends of intracranial aneurysms in patients with intracranial dural arteriovenous fistulas
T2 - a Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR) investigation
AU - the Consortium for Dural Arteriovenous Fistula Outcomes Research
AU - Abecassis, Isaac Josh
AU - Meyer, R. Michael
AU - Levitt, Michael R.
AU - Sheehan, Jason P.
AU - Chen, Ching Jen
AU - Gross, Bradley A.
AU - Lockerman, Ashley
AU - Fox, W. Christopher
AU - Brinjikji, Waleed
AU - Lanzino, Giuseppe
AU - Starke, Robert M.
AU - Chen, Stephanie H.
AU - Potgieser, Adriaan R.E.
AU - van Dijk, J. Marc
AU - Durnford, Andrew
AU - Bulters, Diederik
AU - Satomi, Junichiro
AU - Tada, Yoshiteru
AU - Kwasnicki, Amanda
AU - Amin-Hanjani, Sepideh
AU - Alaraj, Ali
AU - Samaniego, Edgar A.
AU - Hayakawa, Minako
AU - Derdeyn, Colin P.
AU - Winkler, Ethan
AU - Abla, Adib
AU - Lai, Pui Man Rosalind
AU - Du, Rose
AU - Guniganti, Ridhima
AU - Kansagra, Akash P.
AU - Zipfel, Gregory J.
AU - Kim, Louis J.
AU - Piccirillo, Jay F.
AU - Raman, Hari
AU - Lipsey, Kim
AU - Giordan, Enrico
AU - Vine, Roanna
AU - Cloft, Harry J.
AU - Kallmes, David F.
AU - Pollock, Bruce E.
AU - Link, Michael J.
AU - Patibandla, Mohana Rao
AU - Ding, Dale
AU - Buell, Thomas
AU - Paisan, Gabriella
AU - Kelly, Cory
AU - Duffill, Jonathan
AU - Ditchfield, Adam
AU - Millar, John
AU - Macdonald, Jason
AU - Polifka, Adam J.
AU - Laurent, Dimitri
AU - Hoh, Brian
AU - Smith, Jessica
AU - Lunsford, L. Dade
AU - Jankowitz, Brian T.
AU - Gutierrez, Santiago Ortega
AU - Hasan, David
AU - Roa, Jorge A.
AU - Rossen, James
AU - Guerrero, Waldo
AU - McGruder, Allen
AU - Charbel, Fady T.
AU - Aletich, Victor A.
AU - Rose-Finnell, Linda
AU - Peterson, Eric C.
AU - Yavagal, Dileep R.
AU - Sur, Samir
AU - Kanematsu, Yasuhisa
AU - Yamamoto, Nobuaki
AU - Kinouchi, Tomoya
AU - Korai, Masaaki
AU - Yamaguchi, Izumi
AU - Yamamoto, Yuki
AU - Phelps, Ryan R.L.
AU - Lawton, Michael
AU - Rutkowski, Martin
AU - Aziz-Sultan, M. Ali
AU - Patel, Nirav
AU - Frerichs, Kai U.
N1 - Publisher Copyright:
© AANS 2022
PY - 2022/4
Y1 - 2022/4
N2 - OBJECTIVE There is a reported elevated risk of cerebral aneurysms in patients with intracranial dural arteriovenous fistulas (dAVFs). However, the natural history, rate of spontaneous regression, and ideal treatment regimen are not well characterized. In this study, the authors aimed to describe the characteristics of patients with dAVFs and intracranial aneurysms and propose a classification system. METHODS The Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR) database from 12 centers was retrospectively reviewed. Analysis was performed to compare dAVF patients with (dAVF+ cohort) and without (dAVF-only cohort) concomitant aneurysm. Aneurysms were categorized based on location as a dAVF flow-related aneurysm (FRA) or a dAVF non-flow-related aneurysm (NFRA), with further classification as extra- or intradural. Patients with traumatic pseudoaneurysms or aneurysms with associated arteriovenous malformations were excluded from the analysis. Patient demographics, dAVF anatomical information, aneurysm information, and follow-up data were collected. RESULTS Of the 1077 patients, 1043 were eligible for inclusion, comprising 978 (93.8%) and 65 (6.2%) in the dAVFonly and dAVF+ cohorts, respectively. There were 96 aneurysms in the dAVF+ cohort; 10 patients (1%) harbored 12 FRAs, and 55 patients (5.3%) harbored 84 NFRAs. Dural AVF+ patients had higher rates of smoking (59.3% vs 35.2%, p < 0.001) and illicit drug use (5.8% vs 1.5%, p = 0.02). Sixteen dAVF+ patients (24.6%) presented with aneurysm rupture, which represented 16.7% of the total aneurysms. One patient (1.5%) had aneurysm rupture during follow-up. Patients with dAVF+ were more likely to have a dAVF located in nonconventional locations, less likely to have arterial supply to the dAVF from external carotid artery branches, and more likely to have supply from pial branches. Rates of cortical venous drainage and Borden type distributions were comparable between cohorts. A minority (12.5%) of aneurysms were FRAs. The majority of the aneurysms underwent treatment via either endovascular (36.5%) or microsurgical (15.6%) technique. A small proportion of aneurysms managed conservatively either with or without dAVF treatment spontaneously regressed (6.2%). CONCLUSIONS Patients with dAVF have a similar risk of harboring a concomitant intracranial aneurysm unrelated to the dAVF (5.3%) compared with the general population (approximately 2%-5%) and a rare risk (0.9%) of harboring an FRA. Only 50% of FRAs are intradural. Dural AVF+ patients have differences in dAVF angioarchitecture. A subset of dAVF+ patients harbor FRAs that may regress after dAVF treatment.
AB - OBJECTIVE There is a reported elevated risk of cerebral aneurysms in patients with intracranial dural arteriovenous fistulas (dAVFs). However, the natural history, rate of spontaneous regression, and ideal treatment regimen are not well characterized. In this study, the authors aimed to describe the characteristics of patients with dAVFs and intracranial aneurysms and propose a classification system. METHODS The Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR) database from 12 centers was retrospectively reviewed. Analysis was performed to compare dAVF patients with (dAVF+ cohort) and without (dAVF-only cohort) concomitant aneurysm. Aneurysms were categorized based on location as a dAVF flow-related aneurysm (FRA) or a dAVF non-flow-related aneurysm (NFRA), with further classification as extra- or intradural. Patients with traumatic pseudoaneurysms or aneurysms with associated arteriovenous malformations were excluded from the analysis. Patient demographics, dAVF anatomical information, aneurysm information, and follow-up data were collected. RESULTS Of the 1077 patients, 1043 were eligible for inclusion, comprising 978 (93.8%) and 65 (6.2%) in the dAVFonly and dAVF+ cohorts, respectively. There were 96 aneurysms in the dAVF+ cohort; 10 patients (1%) harbored 12 FRAs, and 55 patients (5.3%) harbored 84 NFRAs. Dural AVF+ patients had higher rates of smoking (59.3% vs 35.2%, p < 0.001) and illicit drug use (5.8% vs 1.5%, p = 0.02). Sixteen dAVF+ patients (24.6%) presented with aneurysm rupture, which represented 16.7% of the total aneurysms. One patient (1.5%) had aneurysm rupture during follow-up. Patients with dAVF+ were more likely to have a dAVF located in nonconventional locations, less likely to have arterial supply to the dAVF from external carotid artery branches, and more likely to have supply from pial branches. Rates of cortical venous drainage and Borden type distributions were comparable between cohorts. A minority (12.5%) of aneurysms were FRAs. The majority of the aneurysms underwent treatment via either endovascular (36.5%) or microsurgical (15.6%) technique. A small proportion of aneurysms managed conservatively either with or without dAVF treatment spontaneously regressed (6.2%). CONCLUSIONS Patients with dAVF have a similar risk of harboring a concomitant intracranial aneurysm unrelated to the dAVF (5.3%) compared with the general population (approximately 2%-5%) and a rare risk (0.9%) of harboring an FRA. Only 50% of FRAs are intradural. Dural AVF+ patients have differences in dAVF angioarchitecture. A subset of dAVF+ patients harbor FRAs that may regress after dAVF treatment.
KW - dural arteriovenous fistula
KW - feeding artery aneurysm
KW - vascular disorders
UR - http://www.scopus.com/inward/record.url?scp=85128161342&partnerID=8YFLogxK
U2 - 10.3171/2021.1.JNS202861
DO - 10.3171/2021.1.JNS202861
M3 - Article
C2 - 34507300
AN - SCOPUS:85128161342
SN - 0022-3085
VL - 136
SP - 971
EP - 980
JO - Journal of neurosurgery
JF - Journal of neurosurgery
IS - 4
ER -